Clemedi

Clemedi Develops In Vitro Diagnostic Tests for Infectious Diseases by Combining Two New Technologies (Next-Generation Sequencing and Machine Learning)Clemedi has developed in vitro diagnostic tests for infectious diseases by combining two new technologies: next-generation sequencing and machine learning. These tests will help limit the deaths caused by antibiotic-resistant bacteria, which are projected to reach 10 million annually by 2050! Our diagnostic tests support physicians' decision-making, enabling them to provide timely and personalized antibiotic treatments. Ultimately, patients with infectious diseases will benefit from their products.